Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
Titel:
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
Auteur:
Reilmann, Ralf McGarry, Andrew Grachev, Igor D Savola, Juha-Matti Borowsky, Beth Eyal, Eli Gross, Nicholas Langbehn, Douglas Schubert, Robin Wickenberg, Anna Teige Papapetropoulos, Spyros Hayden, Michael Squitieri, Ferdinando Kieburtz, Karl Landwehrmeyer, G Bernhard